Company intelligence / Profile preview
BioLeonhardt
Mission Viejo, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Developing implantable bioelectric stimulator and refillable stem cell pump for heart regeneration; planned large animal studies in 2022 combining S100A1 expression with stem cells and other factors[2][3].
- Therapeutic areas
- Cardiovascular
- Modalities
- Cell therapyGene therapyProteinDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Leonhardt VenturesCalifornia Medical Innovations InstituteBiomericsQIG
Beyond the preview
Go deeper on BioLeonhardt.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioLeonhardt.